1. Mixture of three amino acids as stabilizers replacing albumin in lyophilization of new third generation recombinant factor VIII GreenGene F
- Author
-
Jae Wook Huh, Young In Park, Sang Hoon Paik, Sang Kyul Han, Yong Jae Kim, and Jean Man Kim
- Subjects
Sucrose ,Excipient ,Polysorbates ,Mice, Transgenic ,law.invention ,Excipients ,Mice ,In vivo ,law ,Albumins ,medicine ,Side chain ,Organic chemistry ,Animals ,Humans ,Amino Acids ,chemistry.chemical_classification ,Chromatography ,Factor VIII ,Chemistry ,Protein Stability ,Albumin ,Recombinant Proteins ,Amino acid ,Freeze Drying ,Recombinant DNA ,Electrophoresis, Polyacrylamide Gel ,Protein stabilization ,Biotechnology ,medicine.drug ,Stabilizer (chemistry) - Abstract
A formulation with stabilizers replacing albumin was developed for lyophilization of recombinant factor VIII (FVIII), GreenGene F (WHO INN: beroctocog alfa), to achieve stability and eliminate safety issues of blood-derived albumin. L-Arginine (hydrophilic amino acid, positively charged side chain), L-glutamic acid (hydrophilic amino acid, negatively charged side chain), and L-isoleucine (hydrophobic amino acid, nonpolar) were selected as stabilizers, and the mixture of the three amino acids were optimized. The mixture had results comparative with albumin and other commonly used stabilizers showing good preservation of recombinant FVIII during lyophilization, robust stability with consistently high recovery of FVIIII, very low aggregate formation, and good storage stability without alterations in protein characteristics. In vivo test results showed that the efficacy was maintained and had no signs of toxicity. The study demonstrated that the three amino acid mixture acts as a good stabilizer for lyophilization of recombinant FVIII and as a safe excipient. © 2012 American Institute of Chemical Engineers Biotechnol. Prog., 2012
- Published
- 2012